Schizophrenia News and Research

Latest Schizophrenia News and Research

Drugmakers raised prices last year in anticipation of new health law, Eli Lilly reports financial hit

"Drug companies sharply raised prices last year, ahead of increased rebates they must pay to Medicaid and other expenses tied to the federal health overhaul passed last month. Prices for brand-name pharmaceuticals rose 9.1% last year, the biggest increase in at least a decade, according to pharmacy-benefit manager Express Scripts Inc."

21 Apr 2010

Systems biologists integrate new genetic framework to help predict adverse drug reactions

In a major step toward predicting adverse drug reactions, systems biologists at Mount Sinai School of Medicine in New York City have integrated genetic, cellular and clinical information to find out why certain medicines can trigger fatal heart arrhythmias.

21 Apr 2010

Forest Laboratories' fourth-quarter net sales up 11.0% to $995.6M

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $0.07 in the fourth quarter of fiscal 2010.

21 Apr 2010

Cannabis users are at risk for developing anxiety and mood disorders: CAMH study

Research has shown possible links between cannabis use and the onset of Schizophrenia, but a new study from the Centre for Addiction and Mental Health shows that people who use cannabis may also be at risk for developing anxiety and mood disorders.

21 Apr 2010

Exposure to dust after WTC collapse impairs ability to detect odors and sense irritants

Individuals involved in rescue, recovery, demolition, and clean-up after the World Trade Center (WTC) disaster on September 11, 2001, were exposed to a complex mixture of airborne smoke, dust, combustion gases, acid mists, and metal fumes. The impact of this exposure on responders' upper and lower respiratory function has been well documented, but little is known about its impact on their sensitivity to odor and irritants.

19 Apr 2010

RUCDR is poised to become a world leader in human disease and genome studies

Despite the continuing, crippling effects of a nationwide recession, a genetics research laboratory on Rutgers' Busch Campus is experiencing an economic boom.

16 Apr 2010

Study on primary cilia formation may lead to new therapies for ciliopathies

A team of scientists at the University of California, San Diego School of Medicine have identified a network of genes that initiate and manage cilia formation. Although scientists have known about cilia for decades, only recently have they discovered their role in disease. This new discovery, which may lead to new therapies for ciliopathies, will appear in the April 15 edition of Nature.

16 Apr 2010

Working memory maintenance linked with synchronisation of neurons

A research project of the Neuroscience Center of the University of Helsinki sheds light on the neuronal mechanisms sustaining memory traces of visual stimuli in the human brain. The results show that the maintenance of working memory is associated with synchronisation of neurons, which facilitates communication between different parts of the brain. On the basis of interaction between the brain areas, it was even possible to predict the subject's individual working memory capacity.

15 Apr 2010

Alkermes submits VIVITROL sNDA for opioid dependence

Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.

13 Apr 2010

Article One Partners concludes AUTO Patent Studies

Article One Partners, the world's largest patent validation firm, today announced the conclusion of two Patent Studies conducted on behalf of a top global automaker, for which $30,000 has been awarded to two Advisors.

13 Apr 2010

Health care experts brand plan for a “Big Australia” as disaster waiting to happen

Increased immigration rates are set to make Australia’s population hit 36 million by the year 2050 according to Federal Government estimates. This would be a huge leap from the present 22,300,000 people that the nation has today. The added population is being seen as a necessity to ensure economical survival for the country.

13 Apr 2010

Gene mutations may predispose individuals to schizophrenia, says new study

An international study led by Universit- de Montr-al scientists suggests that gene mutations may predispose some individuals to schizophrenia and provides new clues about the causes of this ambiguous disorder.

13 Apr 2010

Semel Institute for Neuroscience and Human Behavior awarded $14.9M for establishing new IPCN

The Semel Institute for Neuroscience and Human Behavior at UCLA has been awarded $14.9 million in American Recovery and Reinvestment Act funds to establish a center dedicated to interdisciplinary research on the role of genetic and environmental factors in neuropsychiatric and behavioral disorders.

13 Apr 2010

Semel Institute for Neuroscience and Human Behavior awarded $14.9M to establish IPCN facility

7 Apr 2010

Study: Genetic mutation in mice elevates risk of stress-induced depression

Depression and schizophrenia can be triggered by environmental stimuli and often occur in response to stressful life events. However, some people have a higher predisposition to develop these diseases, which highlights a role for genetics in determining a person's disease risk.

6 Apr 2010

Genome of Australian zebra finch decoded

Nearly all animals make sounds instinctively, but baby songbirds learn to sing in virtually the same way human infants learn to speak: by imitating a parent.

2 Apr 2010

Molecular mechanism behind mutation in calcium channel protein linked with night blindness

Congenital stationary night blindness, an inherited condition that affects one's ability to see in the dark, is caused by a mutation in a calcium channel protein that shuttles calcium into and out of cells. Now, researchers at the Johns Hopkins University School of Medicine have teased apart the molecular mechanism behind this mutation, uncovering a more general principle of how cells control calcium levels.

2 Apr 2010

Researchers identify link between genetic mutation and schizophrenia

In what may provide the most compelling evidence to date, researchers at Columbia University Medical Center have illuminated how a genetic variant may lead to schizophrenia by causing a disruption in communication between the hippocampus and prefrontal cortex regions of the brain, areas believed to be responsible for carrying out working memory.

2 Apr 2010

Genetic risk factor for schizophrenia can disrupt connectivity at level of single neurons

The strongest known recurrent genetic cause of schizophrenia impairs communications between the brain's decision-making and memory hubs, resulting in working memory deficits, according to a study in mice.

1 Apr 2010

Metabolon awarded U.S. patents for metabolomics methods

Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, announced today the grant of US Patent 7,682,783 and US Patent 7,682,784 entitled "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics". The USPTO awarded the patents to Metabolon on March 23, 2010. The issued claims in the new patents are for uses of metabolomics to identify diagnostic biomarkers for depression and schizophrenia by profiling classes of metabolites in a sample.

1 Apr 2010

Schizophrenia News and Research

Latest Schizophrenia News and Research

Drugmakers raised prices last year in anticipation of new health law, Eli Lilly reports financial hit

Systems biologists integrate new genetic framework to help predict adverse drug reactions

Forest Laboratories' fourth-quarter net sales up 11.0% to $995.6M

Cannabis users are at risk for developing anxiety and mood disorders: CAMH study

Exposure to dust after WTC collapse impairs ability to detect odors and sense irritants

RUCDR is poised to become a world leader in human disease and genome studies

Study on primary cilia formation may lead to new therapies for ciliopathies

Working memory maintenance linked with synchronisation of neurons

Alkermes submits VIVITROL sNDA for opioid dependence

Article One Partners concludes AUTO Patent Studies

Health care experts brand plan for a “Big Australia” as disaster waiting to happen

Gene mutations may predispose individuals to schizophrenia, says new study

Semel Institute for Neuroscience and Human Behavior awarded $14.9M for establishing new IPCN

Semel Institute for Neuroscience and Human Behavior awarded $14.9M to establish IPCN facility

Study: Genetic mutation in mice elevates risk of stress-induced depression

Genome of Australian zebra finch decoded

Molecular mechanism behind mutation in calcium channel protein linked with night blindness

Researchers identify link between genetic mutation and schizophrenia

Genetic risk factor for schizophrenia can disrupt connectivity at level of single neurons

Metabolon awarded U.S. patents for metabolomics methods

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Schizophrenia News and Research

Latest Schizophrenia News and Research

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in